Related references
Note: Only part of the references are listed.Efficacy and Safety of an Investigational Single-Course CRISPR Base-Editing Therapy Targeting PCSK9 in Nonhuman Primate and Mouse Models
Richard G. Lee et al.
CIRCULATION (2023)
Efficacy and Safety of an Investigational Single-Course CRISPR Base-Editing Therapy Targeting PCSK9 in Nonhuman Primate and Mouse Models
Richard G. Lee et al.
CIRCULATION (2023)
Analysis of rare genetic variation underlying cardiometabolic diseases and traits among 200,000 individuals in the UK Biobank
Sean J. Jurgens et al.
NATURE GENETICS (2022)
Coronary Artery Disease Risk of Familial Hypercholesterolemia Genetic Variants Independent of Clinically Observed Longitudinal Cholesterol Exposure
Shoa L. Clarke et al.
CIRCULATION-GENOMIC AND PRECISION MEDICINE (2022)
How to live to 100 before developing clinical coronary artery disease: a suggestion
Eugene Braunwald
EUROPEAN HEART JOURNAL (2022)
Compounding Benefits of Cholesterol-Lowering Therapy for the Reduction of Major Cardiovascular Events: Systematic Review and Meta-Analysis
Nelson Wang et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2022)
The power of genetic diversity in genome-wide association studies of lipids
Sarah E. Graham et al.
NATURE (2021)
Sequencing of 53,831 diverse genomes from the NHLBI TOPMed Program
Daniel Taliun et al.
NATURE (2021)
In vivo CRISPR base editing of PCSK9 durably lowers cholesterol in primates
Kiran Musunuru et al.
NATURE (2021)
The ARIC (Atherosclerosis Risk In Communities) Study JACC Focus Seminar 3/8
Jacqueline D. Wright et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)
Advancing human genetics research and drug discovery through exome sequencing of the UK Biobank
Joseph D. Szustakowski et al.
NATURE GENETICS (2021)
Sequencing of 640,000 exomes identifies GPR75 variants associated with protection from obesity
Parsa Akbari et al.
SCIENCE (2021)
Association Between Cumulative Low-Density Lipoprotein Cholesterol Exposure During Young Adulthood and Middle Age and Risk of Cardiovascular Events
Yiyi Zhang et al.
JAMA CARDIOLOGY (2021)
Age-related trends in lipid levels: a large-scale cross-sectional study of the general Chinese population
Lei Feng et al.
BMJ OPEN (2020)
A missense variant in Mitochondrial Amidoxime Reducing Component 1 gene and protection against liver disease
Connor A. Emdin et al.
PLOS GENETICS (2020)
The mutational constraint spectrum quantified from variation in 141,456 humans
Konrad J. Karczewski et al.
NATURE (2020)
Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol
Kausik K. Ray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Inclisiran for the Treatment of Heterozygous Familial Hypercholesterolemia
Frederick J. Raal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Association of Rare Pathogenic DNA Variants for Familial Hypercholesterolemia, Hereditary Breast and Ovarian Cancer Syndrome, and Lynch Syndrome With Disease Risk in Adults According to Family History
Aniruddh P. Patel et al.
JAMA NETWORK OPEN (2020)
Time Course of LDL Cholesterol Exposure and Cardiovascular Disease Event Risk
Michael J. Domanski et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Polygenic background modifies penetrance of monogenic variants for tier 1 genomic conditions
Akl C. Fahed et al.
NATURE COMMUNICATIONS (2020)
Lipid profile changes during the menopausal transition
Veronica Inaraja et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2020)
Efficacy and Safety of Mipomersen: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
Federica Fogacci et al.
DRUGS (2019)
Rare Protein-Truncating Variants in APOB, Lower Low-Density Lipoprotein Cholesterol, and Protection Against Coronary Heart Disease
Gina M. Peloso et al.
CIRCULATION-GENOMIC AND PRECISION MEDICINE (2019)
Association of Genetic Variants Related to Combined Exposure to Lower Low-Density Lipoproteins and Lower Systolic Blood Pressure With Lifetime Risk of Cardiovascular Disease
Brian A. Ference et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
20-Year Follow-up of Statins in Children with Familial Hypercholesterolemia
I. K. Luirink et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Harmonization of Respiratory Data From 9 US Population-Based Cohorts The NHLBI Pooled Cohorts Study
Elizabeth C. Oelsner et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2018)
Analysis of predicted loss-of-function variants in UK Biobank identifies variants protective for disease
Connor A. Emdin et al.
NATURE COMMUNICATIONS (2018)
The UK Biobank resource with deep phenotyping and genomic data
Clare Bycroft et al.
NATURE (2018)
Large-Scale Phenome-Wide Association Study of PCSK9 Variants Demonstrates Protection Against Ischemic Stroke
Abhiram S. Rao et al.
CIRCULATION-GENOMIC AND PRECISION MEDICINE (2018)
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
Brian A. Ference et al.
EUROPEAN HEART JOURNAL (2017)
ANGPTL3 Deficiency and Protection Against Coronary Artery Disease
Nathan O. Stitziel et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Exome-wide association study of plasma lipids in >300,000 individuals
Dajiang J. Liu et al.
NATURE GENETICS (2017)
Genetics of coronary artery disease: discovery, biology and clinical translation
Amit V. Khera et al.
NATURE REVIEWS GENETICS (2017)
PCSK9 Loss-of-Function Variants, Low-Density Lipoprotein Cholesterol, and Risk of Coronary Heart Disease and Stroke Data From 9 Studies of Blacks and Whites
Shia T. Kent et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2017)
Familial hypercholesterolaemia
Joep C. Defesche et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
Comparison of Sociodemographic and Health-Related Characteristics of UK Biobank Participants With Those of the General Population
Anna Fry et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2017)
Complexity of mechanisms among human proprotein convertase subtilisin-kexin type 9 variants
Jacqueline S. Dron et al.
CURRENT OPINION IN LIPIDOLOGY (2017)
Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions A Systematic Review and Meta-analysis
Michael G. Silverman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Diagnostic Yield and Clinical Utility of Sequencing Familial Hypercholesterolemia Genes in Patients With Severe Hypercholesterolemia
Amit V. Khera et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Inactivating Variants in ANGPTL4 and Risk of Coronary Artery Disease
Frederick F. Dewey et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age
Cathie Sudlow et al.
PLOS MEDICINE (2015)
Inactivating Mutations in NPC1L1 and Protection from Coronary Heart Disease
Nathan O. Stitziel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Loss-of-Function Mutations in APOC3, Triglycerides, and Coronary Disease
Jacy Crosby et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Mipomersen, an apolipoprotein B synthesis inhibitor, lowers low-density lipoprotein cholesterol in high-risk statin-intolerant patients: a randomized, double-blind, placebo-controlled trial
Maartje E. Visser et al.
EUROPEAN HEART JOURNAL (2012)
Effect of Long-Term Exposure to Lower Low-Density Lipoprotein Cholesterol Beginning Early in Life on the Risk of Coronary Heart Disease A Mendelian Randomization Analysis
Brian A. Ference et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Sequence variations in PCSK9, low LDL, and protection against coronary heart disease
JC Cohen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9
C Jonathan et al.
NATURE GENETICS (2005)
Familial hypobetalipoproteinemia: a review
G Schonfeld
JOURNAL OF LIPID RESEARCH (2003)
Multi-ethnic study of atherosclerosis: Objectives and design
DE Bild et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2002)